Vestiage Engages ROI Media for Direct Response Advertising
December 11 2013 - 12:00AM
Business Wire
Vestiage, Inc. (Pink Sheets: VEST), a publicly traded
healthy aging lifestyle company focused on science-based premium
branded highly potent cosmeceuticals and nutraceuticals, announced
today that it has engaged ROI Media to orchestrate its direct to
consumer marketing campaign. ROI Media is a recognized leader in
radio advertising and is known for its award-winning radio and
television campaigns for multiple major brands.
(www.ROImediadirect.com)
"At this stage of our growth, it is time for us to engage the
best people in the business to drive sales through multiple
channels," said Scott Kimball, CEO of Vestiage. "ROI has proven
repeatedly that they can drive major successes in the direct
response and customer acquisition channels such as radio and
television. Clearly these are terrifically talented pros that add a
whole new dimension to Vestiage."
Since the formation of Vestiage, the Company has stated that its
model would be to sell products through multiple channels. In 2014
the Company will have multiple brands entering several channels
including retail, internet, and now, with the engagement of ROI
Media, the Company will be moving the appropriate products into the
direct to consumer channel. This will also serve to support the
Company's retail oriented marketing and advertising.
"We take on very few new clients, but we see Vestiage as the
emerging leader in their space. Clearly there is no shortage of
nutraceutical companies, but Vestiage is taking the industry to a
new level. Their research and focus on products based upon human
stem cells is the difference maker, and we're proud to have been
chosen as their advertising agency," said Zeus Peleuses, President
of ROI Media Direct.
Vestiage has an active growth plan in place calling for the
creation and acquisition of several healthy aging brand assets over
the next 3-5 years. The acquisition program supports and
accelerates the Company's organic growth plan. The Vestiage R&D
program has resulted in the discovery and/or use of certain
patented botanical and marine ingredients, which are then used in
novel combinations within its brands. Ingredient research and
development, as well as formulations, are done in conjunction with
large industry partners and laboratories assisting in the
development of internally created brands. The Company's Mergers and
Acquisitions team reviews potential acquisition targets regularly.
The Company recently completed the acquisition of the RegiMEN men's
healthy aging system of supplements. Vestiage will launch the
female healthy aging line Monterey Bay Nutraceuticals in January
2014 with production giant Robinson Pharma and botanical ingredient
company Nutragenesis. The line is designed to address the key
issues in high demand for women over 40.
About Vestiage, Inc.
Vestiage (Pink Sheets: VEST) is a publicly traded
anti-aging lifestyle company offering premium branded science-based
cosmeceuticals and nutraceuticals. Vestiage is focused on the use
of human stem cell, marine/ocean, and cutting edge botanically
based science and ingredients to produce highly potent, elegantly
formulated products with clinically proven ingredients. Using high
potency and novel ingredient combinations, Vestiage creates and
distributes cosmeceuticals such as Reluma (http://www.RelumaSkinCare.com) and
multifunctional nutraceuticals through RegiMEN supplements and
Monterey Bay Nutraceuticals (http://www.MontereyBayNutra.com). Vestiage
brands address the top “in demand” anti-aging concerns of men and
women. Vestiage research is focused on longevity and human
performance science that covers both the cognitive and physical
realms. As clinical results validate discoveries, Vestiage intends
to apply new potential ingredients or ingredient formulations and
combinations to its anti-aging products across brands. To learn
more, visit the Company
website, http://www.VestiageInc.com.
This Press Release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
with respect to our financial condition, results of operations and
business. These forward-looking statements can be identified by the
use of terms such as "believe," "expects," "plan," "intend," "may,"
"will," "should," "can," or "anticipates," or the negative thereof,
or variations thereon, or comparable terminology, or by discussions
of strategy. These statements involve known and unknown risks,
uncertainties and other factors that may cause industry trends or
our actual results to be materially different from any future
results expressed or implied by these statements. Important factors
that may cause our results to differ from these forward-looking
statements include, but are not limited to: (i) changes in or new
government regulations or increased enforcement of the same; (ii)
unavailability of desirable acquisitions or inability to complete
them; (iii) increased costs, including from increased raw material
or energy prices; (iv) changes in general worldwide economic or
political conditions; (v) adverse publicity or negative consumer
perception regarding nutritional supplements, anti-aging or stem
cell facial care products or stem cell technology in general; (vi)
issues with obtaining raw materials of adequate quality or
quantity; (vii) litigation and claims, including product liability,
intellectual property and other types; (viii) disruptions from or
following acquisitions including the loss of customers; (ix)
increased competition; (x) slow or negative growth in the
anti-aging or cosmetics, beauty, or nutritional supplement industry
or the healthy foods or anti-aging channel; (xi) the loss of key
personnel or the inability to manage our operations efficiently;
(xii) problems with information management systems, manufacturing
efficiencies and operations; (xiii) insurance coverage issues;
(xiv) the volatility of the stock market generally and of our stock
specifically; (xv) increases in the cost of borrowings or
unavailability of additional debt or equity capital, or both, or
fluctuations in foreign currencies; and (xvi) interruption of
business or negative impact on sales and earnings due to acts of
God, acts of war, terrorism, bio-terrorism, civil unrest and other
factors outside of our control.
Vestiage, Inc.Scott Kimball,
949-258-4404scott@vestiageinc.com
Vestiage (PK) (USOTC:VEST)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vestiage (PK) (USOTC:VEST)
Historical Stock Chart
From Apr 2023 to Apr 2024